Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020-2022)
Description
CONCLUSIONS: This is the first study to investigate the distribution and characteristics of cancer patients diagnosed with COVID-19. Based on the data from our study, bilateral lung involvement is an independent factor for severe disease, and the CRP
